Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis
Authors:
- 13 September 2019
- journal article
- research article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 16 (5) , 180-188
Abstract
The review’s main focus centers on the genetics of hereditary cardiac amyloidosis, highlighting the opportunities and challenges posed by the widespread availability of genetic screening and diagnostic cardiac imaging.Keywords
This publication has 83 references indexed in Scilit:
- Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosisAmyloid, 2013
- 99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac AmyloidosesCirculation: Cardiovascular Imaging, 2013
- Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patientsAmyloid, 2011
- Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variantEuropean Heart Journal, 2011
- Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosisAmerican Heart Journal, 2009
- Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish populationAmyloid, 2008
- Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variantLiver Transplantation and Surgery, 1999
- Selective binding of nifedipine to amylold fibrilsThe American Journal of Cardiology, 1985
- Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agentsThe American Journal of Cardiology, 1985
- Amyloid cardiomyopathy: Characterization by a distinctive voltage/mass relationThe American Journal of Cardiology, 1982